ArticleScientific reports2025
A pharmacovigilance analysis of post-marketing safety of durvalumab.
An-Ju Tan et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
4 papers cite it
this papercites it
ArticleScientific reports2025
An-Ju Tan et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.